Floatz logo

373 assets in Non-Hodgkin Lymphoma

Therapeutic assets addressing Non-Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
cd79b-19 car t cells
Non-Hodgkin Lymphoma
Marcela V. Maus, M.D.,Ph.D.P1C (39)
Clic-2201
Non-Hodgkin Lymphoma
British Columbia Cancer AgencyP1C (39)
Docirbrutinib
Non-Hodgkin Lymphoma
Carna Biosciences, Inc.P1C (39)
Ebv-Specific T Cells: B
Non-Hodgkin Lymphoma
Baylor College of MedicineP1C (39)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer CenterP1C (39)
Exercise Mobilized Prophylactic Dli
Non-Hodgkin Lymphoma
University of ArizonaP1C (39)
gb5005 cart
Non-Hodgkin Lymphoma
The First Affiliated Hospital of Xiamen UniversityP1C (39)
Glb-002
Non-Hodgkin Lymphoma
Hangzhou GluBio Pharmaceutical Co., Ltd.P1C (39)
Hucart19-Il18
Non-Hodgkin Lymphoma
University of PennsylvaniaP1C (39)
Icaspase9-Transduced T Cells
Non-Hodgkin Lymphoma
Baylor College of MedicineP1C (39)
Icovamenib
Non-Hodgkin Lymphoma
Biomea Fusion Inc.P1C (39)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Non-Hodgkin Lymphoma
OncoNano Medicine, Inc.P1C (39)
jlm019
Non-Hodgkin Lymphoma
Jecho Biopharmaceuticals Co., Ltd.P1C (39)
Jnj-54179060
Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1C (39)
Jnj-70218902
Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1C (39)
Jnj-74856665
Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1C (39)
Jnj-80948543
Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1C (39)
Jnj-87801493
Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1C (39)
Jnj-88998377
Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1C (39)
Jnj-95566692
Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1C (39)
ksv01
Non-Hodgkin Lymphoma
TCRx Therapeutics Co.LtdP1C (39)
Ksvcbd
Non-Hodgkin Lymphoma
Chinese PLA General HospitalP1C (39)
Loxo-338
Non-Hodgkin Lymphoma
Eli Lilly and CompanyP1C (39)
ly4152199 - iv
Non-Hodgkin Lymphoma
Eli Lilly and CompanyP1C (39)
Mabel Ctls
Non-Hodgkin Lymphoma
Baylor College of MedicineP1C (39)
Murine Cd19 Car-T Cells
Non-Hodgkin Lymphoma
Zhejiang UniversityEarly P1C (39)
nkx019
Non-Hodgkin Lymphoma
Nkarta, Inc.P1C (39)
Onm-501
Non-Hodgkin Lymphoma
OncoNano Medicine, Inc.P1C (39)
Ono-7018
Non-Hodgkin Lymphoma
Ono Pharmaceutical Co., Ltd.P1C (39)
Oriv508
Non-Hodgkin Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyEarly P1C (39)
Pace Cart19
Non-Hodgkin Lymphoma
University of PennsylvaniaP1C (39)
Pediatric Multitaa T Cells Stage
Non-Hodgkin Lymphoma
Baylor College of MedicineP1C (39)
pf-08046045
Non-Hodgkin Lymphoma
Seagen, a wholly owned subsidiary of PfizerP1C (39)
pic1
Non-Hodgkin Lymphoma
Chongqing Precision Biotech Co., LtdP1C (39)
qlf31907
Non-Hodgkin Lymphoma
Qilu Pharmaceutical Co., Ltd.P1C (39)
Recombinant Human Granulocyte Colony-Stimulating Factor
Non-Hodgkin Lymphoma
City of Hope Medical CenterP1C (39)
ro7443904
Non-Hodgkin Lymphoma
Hoffmann-La RocheP1C (39)
sc291
Non-Hodgkin Lymphoma
Sana BiotechnologyP1C (39)
Scr-6920
Non-Hodgkin Lymphoma
Jiangsu Simcere Pharmaceutical Co., Ltd.P1C (39)
Sgr-1505
Non-Hodgkin Lymphoma
Schrödinger, Inc.P1C (39)
Tgfbeta Resistant Lmp-Specific Ctls
Non-Hodgkin Lymphoma
Baylor College of MedicineP1C (39)
Thiscart19A
Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow UniversityP1C (39)
Uf-Kure19 Car-T Cells
Non-Hodgkin Lymphoma
David WaldP1C (39)
Ulintoclax Pegondrimer
Non-Hodgkin Lymphoma
AstraZenecaP1C (39)
Vactosertib
Non-Hodgkin Lymphoma
David WaldP1C (39)
1-118-Signal regulatory protein ? (human) fusion protein with immunoglobulin G4 [128-proline] (human ?4-chain C region C-terminal fragment), dimer
Non-Hodgkin Lymphoma
PfizerP1C (38)
Anti-Pd-L1 Monoclonal Antibody Ck-301
Non-Hodgkin Lymphoma
Checkpoint Therapeutics, Inc.P1C (38)
Hyaluronidase Fihj
Non-Hodgkin Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsEarly P1C (38)
Boclatixafortide
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer CenterEarly P1C (36)
cd70-targeting car-t cells
Non-Hodgkin Lymphoma
Zhejiang UniversityEarly P1C (36)
Showing 301 to 350 of 373 assets
PreviousPage 7 of 8Next